CV Advisors’s Pfizer PFE Stock Holding History

CV Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$747K	Hold	26,200	–	–	0.13%	68
2026 Q2	$631K	Buy	+26,200	New	+$685K	0.12%	73

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

CV Advisors's PFE Position: Q3 2026 in Review

CV Advisors held its Pfizer (PFE) position steady in Q3 2026 at 26,200 shares worth $747K. The position accounts for 0.13% of the portfolio, ranked #68.

CV Advisors first reported a position in PFE in Q2 2026 and has held it in 2 quarters since. 820 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

CV Advisors held 26,200 shares of Pfizer worth $747K as of Q3 2026.
CV Advisors left its Pfizer share count unchanged in Q3 2026.
Pfizer made up 0.13% of CV Advisors's portfolio in Q3 2026, its #68 holding.
CV Advisors first reported a position in Pfizer in Q2 2026 and has held it in 2 quarters since.
820 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on CV Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.